Cargando…

Advanced non-small cell lung cancer in patients aged 45 years or younger: outcomes and prognostic factors

BACKGROUND: Lung cancer in young patients (less or equal to 45 years) is uncommon and has clinical characteristics different from that in older patients. We investigated the outcomes and prognostic factors of young patients with advanced non-small cell lung cancer (NSCLC). METHODS: From January 2000...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Chia-Lin, Chen, Kuan-Yu, Shih, Jin-Yuan, Ho, Chao-Chi, Yang, Chih-Hsin, Yu, Chong-Jen, Yang, Pan-Chyr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420246/ https://www.ncbi.nlm.nih.gov/pubmed/22695392 http://dx.doi.org/10.1186/1471-2407-12-241

Ejemplares similares

Adrenal insufficiency in prolonged critical illness
por: Wu, Jenn-Yu, et al.
Publicado: (2008)

Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinoma
por: Chang, Chia-Ling, et al.
Publicado: (2022)

Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression
por: Chen, Chung-Yu, et al.
Publicado: (2017)

Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in Taiwan
por: Lin, Shu-Yung, et al.
Publicado: (2018)

Timing of tracheostomy as a determinant of weaning success in critically ill patients: a retrospective study
por: Hsu, Chia-Lin, et al.
Publicado: (2005)

Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitors
por: Huang, Chun-Ta, et al.
Publicado: (2023)

Outcome and prognostic factors in critically ill patients with systemic lupus erythematosus: a retrospective study
por: Hsu, Chia-Lin, et al.
Publicado: (2005)

Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer
por: Lu, Shao-Lun, et al.
Publicado: (2016)

Precision radiotherapy for non-small cell lung cancer
por: Yang, Wen-Chi, et al.
Publicado: (2020)

Glasgow prognostic score after concurrent chemoradiotherapy is a prognostic factor in advanced head and neck cancer
por: Chang, Pei-Hung, et al.
Publicado: (2017)

Younger adults with mild-to-moderate COVID-19 exhibited more prevalent olfactory dysfunction in Taiwan
por: Cheng, Meng-Yu, et al.
Publicado: (2021)

Circulating microparticles are prognostic biomarkers in advanced non-small cell lung cancer patients
por: Wang, Chin-Chou, et al.
Publicado: (2017)

Expression of Notch Gene and Its Impact on Survival of Patients with Resectable Non-small Cell Lung Cancer
por: Chen, Chung-Yu, et al.
Publicado: (2017)

The Role of PIK3CA Mutations among Lung Adenocarcinoma Patients with Primary and Acquired Resistance to EGFR Tyrosine Kinase Inhibition
por: Wu, Shang-Gin, et al.
Publicado: (2016)

Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors
por: Wu, Shang-Gin, et al.
Publicado: (2017)

Fracture in Asian Women with Breast Cancer Occurs at Younger Age
por: Tsa, Chun-Hao, et al.
Publicado: (2013)

Gender-Based Impact of Epidermal Growth Factor Receptor Mutation in Patients With Nonsmall Cell Lung Cancer and Previous Tuberculosis
por: Chang, Chia-Hao, et al.
Publicado: (2015)

Empyema Thoracis from Salmonella Choleraesuis
por: Lai, Chih-Cheng, et al.
Publicado: (2005)

The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
por: Wu, Shang-Gin, et al.
Publicado: (2016)

Correction: Fracture in Asian Women with Breast Cancer Occurs at Younger Age
por: Tsai, Chun-Hao, et al.
Publicado: (2013)

A Novel Prognostic DNA Methylation Panel for Colorectal Cancer
por: Chung, Hsin-Hua, et al.
Publicado: (2019)

Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC
por: Liao, Bin-Chi, et al.
Publicado: (2020)

Effect of β-Blocker in Treatment-Naïve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs
por: Chang, Chia-Hao, et al.
Publicado: (2020)

Outcomes of Anterior Cruciate Ligament Reconstruction in Patients Older Than 50 Years and Younger Than 30 Years
por: Weng, Chun-Jui, et al.
Publicado: (2022)

Positive Fecal Immunochemical Test Strongly Predicts Adenomas in Younger Adults With Fatty Liver and Metabolic Syndrome
por: Yeh, Jen-Hao, et al.
Publicado: (2021)

Gefitinib or erlotinib in previously treated non–small‐cell lung cancer patients: a cohort study in Taiwan
por: Chang, Chia‐Hao, et al.
Publicado: (2017)

Correction to: Positive Fecal Immunochemical Test Strongly Predicts Adenomas in Younger Adults With Fatty Liver and Metabolic Syndrome
por: Yeh, Jen-Hao, et al.
Publicado: (2021)

Trends and predictors of changes in pulmonary function after treatment for pulmonary tuberculosis
por: Chung, Kuei-Pin, et al.
Publicado: (2011)

Pulmonary benign metastasizing leiomyoma in patients aged 45 years and younger: clinical features and novelty in treatment
por: Su, Hao, et al.
Publicado: (2023)

Expression of large tumour suppressor (LATS) kinases modulates chemotherapy response in advanced non-small cell lung cancer
por: Luo, Susan Yang, et al.
Publicado: (2020)

Small-molecule PIK-93 modulates the tumor microenvironment to improve immune checkpoint blockade response
por: Lin, Chia-Yi, et al.
Publicado: (2023)

Optimal Threshold of Homeostasis Model Assessment of Insulin Resistance to Identify Metabolic Syndrome in a Chinese Population Aged 45 Years or Younger
por: Lin, Szu-Yu, et al.
Publicado: (2022)

Serum Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Acute Respiratory Distress Syndrome: A Prospective Observational Cohort Study
por: Lin, Ming-Tzer, et al.
Publicado: (2010)

Prevention of elastase-induced emphysema in placenta growth factor knock-out mice
por: Cheng, Shih Lung, et al.
Publicado: (2009)

Clinical Implications of Nonbiological Factors With Colorectal Cancer Patients Younger Than 45 Years
por: Liu, Qi, et al.
Publicado: (2021)

Pretreatment prognostic nutritional index as a prognostic marker in head and neck cancer: a systematic review and meta-analysis
por: Luan, Chih-Wei, et al.
Publicado: (2021)

Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study
por: Liang, Sheng-Kai, et al.
Publicado: (2018)

Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan
por: Wu, Shang-Gin, et al.
Publicado: (2020)

Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily Practice
por: Liang, Yi-Hsin, et al.
Publicado: (2016)

The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation
por: Wu, Shang-Gin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8qlsali35bu8t2d85qfg9nopd3